HPV Vaccination and Substantial Reduction in Cervical Cancer HPV Vaccination and Substantial Reduction in Cervical Cancer
A review from Sweden of more than 1 million girls/women vaccinated in 2006 – 2017 shows a substantial reduction in the risk for invasive cervical cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 1, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Giving the HPV vaccine to schoolgirls 'slashes risk of cervical cancer by 88%'
In the biggest study yet to evaluate the success of the vaccine, experts at the Karolinska Institutet in Sweden followed 1.7million women over 11 years. Around 500,000 had received the jab. (Source: the Mail online | Health)
Source: the Mail online | Health - September 30, 2020 Category: Consumer Health News Source Type: news

HPV vaccine 'may significantly' lower cervical cancer risk, study finds
Women vaccinated against HPV may be at significantly lower risk for developing cervical cancer, according to a study published Wednesday by the New England Journal of Medicine. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 30, 2020 Category: Consumer Health News Source Type: news

HPV Vaccine Proves Its Mettle Against Cervical Cancer
WEDNESDAY, Sept. 30, 2020 -- Girls who are vaccinated against human papillomavirus (HPV) may drastically cut their chances of developing cervical cancer by age 30, a huge, new study finds. Researchers found that of more than 1.6 million young... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 30, 2020 Category: General Medicine Source Type: news

HPV vaccine effective against cervical cancer
(Karolinska Institutet) Women vaccinated against HPV have a significantly lower risk of developing cervical cancer, and the positive effect is most pronounced for women vaccinated at a young age. That is according to a large study by researchers at Karolinska Institutet in Sweden published in New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 30, 2020 Category: Cancer & Oncology Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Investor Update - September 16, 2020 Category: Pharmaceuticals Source Type: news

A Marathon, Not a Sprint: Peru Needs Fiscal Reforms to Quell High COVID-19 Death Rate
Intercultural bilingual school at Andahuaylas province, Peru. Photo courtesy Sergio Chaparro Hernández (CESR) By Laura Adriaensens and Sergio Chaparro HernándezANTWERP, Belgium / BOGOTA, Colombia, Sep 11 2020 (IPS) “It’s a major paradox, no?” asks Hugo Ñopo, a researcher at the Peruvian think tank Group for the Analysis of Development (GRADE). Since the beginning of the pandemic, Peru has presented itself as an example for the region: it quickly implemented drastic prevention measures, followed scientific recommendations and prepared an economic support plan for the most vulnerable se...
Source: IPS Inter Press Service - Health - September 11, 2020 Category: International Medicine & Public Health Authors: Laura Adriaensens and Sergio Chaparro Hernandez Tags: Development & Aid Editors' Choice Featured Global Headlines Health Human Rights IPS UN: Inside the Glasshouse Latin America & the Caribbean Population Poverty & SDGs Source Type: news

Charity Provides Information On Cervical Screenings For Trans & Non-Binary Patients
One charity has recognized that the language surrounding smear tests and gynecological cancers can be so exclusive that it can put off trans and non-binary patients with deadly consequences. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 9, 2020 Category: Pharmaceuticals Authors: Alice Broster, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Costs of care high in newly diagnosed cervical cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2020 Category: Drugs & Pharmacology Source Type: news

How the COVID-19 Pandemic Has Changed Cancer Care, In 4 Charts
Before the pandemic, about 1,000 new patients came to Boston’s Dana-Farber Cancer Institute for treatment consultations each week. When COVID-19 hit Massachusetts this spring, the number of new consultations fell by half and the hospital moved as many appointments as possible online. Now, with daily case counts relatively low in the area, the hospital is back to scheduling about 800 consultations per week, using a mixture of telemedicine and in-person appointments, says associate chief medical officer Dr. Andrew Wagner—but that still means about 200 cancer patients per week are not getting the treatment consult...
Source: TIME: Health - August 28, 2020 Category: Consumer Health News Authors: Jamie Ducharme and Emily Barone Tags: Uncategorized COVID-19 Source Type: news

Doppler ultrasound helps assess cervical cancer stage
Researchers in China found a link between findings on Doppler ultrasound scans...Read more on AuntMinnie.comRelated Reading: New guidelines standardize Doppler waveform reporting SARS helped Singapore department prepare for COVID-19 ASTRO releases first cervical cancer guidelines FDG-PET/CT points to cervical cancer patient outcomes AI helps characterize breast masses on ultrasound (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 18, 2020 Category: Radiology Source Type: news

Smokers Less Likely to Receive Breast, Cervical, CRC Screening
MONDAY, Aug. 17, 2020 -- Current smokers have lower odds of obtaining cancer screening for breast, cervical, and colorectal cancer, according to a study published online Aug. 13 in BMJ Open. Victor A. Eng, from Stanford University School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 17, 2020 Category: Pharmaceuticals Source Type: news

How Can You Get Cervical Cancer?
Title: How Can You Get Cervical Cancer?Category: Diseases and ConditionsCreated: 8/13/2020 12:00:00 AMLast Editorial Review: 8/13/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 13, 2020 Category: Cancer & Oncology Source Type: news

Most Aggressive Form of Cervical Cancer
Title: Most Aggressive Form of Cervical CancerCategory: Diseases and ConditionsCreated: 8/13/2020 12:00:00 AMLast Editorial Review: 8/13/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 13, 2020 Category: Cancer & Oncology Source Type: news

MobileODT completed $4 million series round C
The round will support the development of AI cervical cancer screening device TEL AVIV, Israel, Aug. 12, 2020 -- (Healthcare Sales & Marketing Network) -- MobileODT, the developer of the EVA System for cervical cancer screening, announced the completio... Diagnostics, Oncology, Venture Capital MobileODT, EVA System, VisualCheck, cervical cancer screening (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 12, 2020 Category: Pharmaceuticals Source Type: news

AI Improves Diagnostic Accuracy in Cervical Cancer AI Improves Diagnostic Accuracy in Cervical Cancer
Another diagnostic win for deep learning, with a computer model outperforming traditional radiology in identifying lymph node involvement in cervical cancer.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - August 11, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Analysis of Ugandan cervical carcinomas, an aid for understudied sub-Saharan women
(University of Alabama at Birmingham) Cervical cancer kills more than 300,000 middle-aged women a year, and 19 of the 20 nations with the highest death rates are sub-Saharan countries. Now an international team, including Akinyemi I. Ojesina, M.D., Ph.D., University of Alabama at Birmingham, has published the first comprehensive genomic study of cervical cancers in sub-Saharan Africa, with a focus on tumors from 212 Ugandan patients with cervical cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 10, 2020 Category: Cancer & Oncology Source Type: news

HPV Test Is Preferred for Cervical Cancer Screen
HPV Test Is Preferred Method for Cervical Cancer Screening: ACS (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 5, 2020 Category: General Medicine Source Type: news

HPV vaccination linked to lower risk of precancerous condition
(Wiley) Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 5, 2020 Category: Cancer & Oncology Source Type: news

HPV Test Is Preferred Method for Cervical Cancer Screening: ACS HPV Test Is Preferred Method for Cervical Cancer Screening: ACS
New guidelines recommend human papillomavirus (HPV) testing as the preferred screening method, but cotesting and cytology alone are still acceptable options.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 4, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Relationship of perception with community attitudes about handling prehospital prevention of cervical injury risk in traffic accident patients in Watdek Village Maluku Tenggara - Anggraini NA, Ambarika R, Fawzi A, Sanaty BA, Sansuwito TB.
Accidents are the fourth cause of death, after heart disease, cancer and stroke, ±50 increases per year 100,000 population each year, 3% of the causes of death are due to direct spinal cord trauma, 2% due to multiple trauma. Attitudes or responses are ver... (Source: SafetyLit)
Source: SafetyLit - July 31, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

American Cancer Society now recommends cervical cancer screening start at 25, not 21
Individuals with a cervix are now recommended to start cervical cancers screening at 25 and continue through age 65, with the primary human papillomavirus (HPV) testing every five years as the preferred method of testing, according to a new guideline released Thursday by the American Cancer Society. (Source: CNN.com - Health)
Source: CNN.com - Health - July 31, 2020 Category: Consumer Health News Source Type: news

American Cancer Society Recommends HPV Test for Cervical Cancer Screening
Title: American Cancer Society Recommends HPV Test for Cervical Cancer ScreeningCategory: Health NewsCreated: 7/30/2020 12:00:00 AMLast Editorial Review: 7/31/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 31, 2020 Category: Cancer & Oncology Source Type: news

American Cancer Society Recommends HPV Test
The new guideline calls for an initial cervix screening at age 25, followed by the human papillomavirus (HPV) test every five years, continuing through age 65, the guideline says. (Source: WebMD Health)
Source: WebMD Health - July 31, 2020 Category: Consumer Health News Source Type: news

ACS Issues Updated Guideline for Cervical Cancer Screening
Screening, preferably with primary HPV testing, should start at age 25 and continue through age 65 (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 30, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Nursing, Oncology, Pathology, Journal, Source Type: news

American Cancer Society Recommends HPV Test for Cervical Cancer Screening
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 30, 2020 Category: Cancer & Oncology Tags: Gynecology, Infections, Oncology, Preventive Medicine, News, Source Type: news

American Cancer Society Updates Screening Guidelines For Cervical Cancer
New guidelines for cervical cancer screening raises concern from some doctors. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 30, 2020 Category: Pharmaceuticals Authors: Marla Milling, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

American Cancer Society Recommends HPV Test for Cervical Cancer Screening
THURSDAY, July 30, 2020 -- An updated guideline from the American Cancer Society calls for more simplified cervical cancer screening, administered less often. The new guideline calls for an initial cervix screening at age 25, followed by the human... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 30, 2020 Category: General Medicine Source Type: news

ACS Issues Updated Guideline for Cervical Cancer Screening
THURSDAY, July 30, 2020 -- In a guideline update from the American Cancer Society, published online July 30 in CA: A Cancer Journal for Clinicians, recommendations are presented for cervical cancer screening of individuals at average risk. Elizabeth... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 30, 2020 Category: Pharmaceuticals Source Type: news

Most women treated in New York City for gynecologic cancers
(NYU Langone Health / NYU School of Medicine) Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 30, 2020 Category: International Medicine & Public Health Source Type: news

American Cancer Society updates guideline for cervical cancer screening
(American Cancer Society) An updated cervical cancer screening guideline from the American Cancer Society reflects the rapidly changing landscape of cervical cancer prevention in the United States, calling for less and more simplified screening. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 30, 2020 Category: Cancer & Oncology Source Type: news

ASTRO Issues First Guideline on Radiation Therapy for Cervical Cancer
FRIDAY, July 24, 2020 -- There is strong evidence supporting the use of radiation therapy (RT) for nonmetastatic cervical cancer, according to a clinical practice guideline from the American Society for Radiation Oncology (ASTRO) published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2020 Category: Pharmaceuticals Source Type: news

AI spots cervical cancer lymph node metastasis on MRI
An artificial intelligence (AI) algorithm was able to preoperatively identify...Read more on AuntMinnie.comRelated Reading: Textural analysis improves breast MRI's accuracy ASTRO releases first cervical cancer guidelines Model predicts metastases in endometrial cancer patients Caution urged for breast MRI evaluation of lymph nodes AI may predict lymph node metastasis in gastric cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 24, 2020 Category: Radiology Source Type: news

A novel tissue imaging system accelerates cancer diagnosis
(Osaka University) Researchers from Osaka University developed a novel three-dimensional imaging system to diagnose cervical cancer in a faster, non-invasive and more efficient way than the conventional approach. They showed that their imaging tool enables an accurate classification of cervical tissues into healthy or various forms of cancer when coupled with deep learning. These findings could improve the diagnostic approach for cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 23, 2020 Category: Cancer & Oncology Source Type: news

The impact of intimate partner violence on breast and cervical cancer survivors in an integrated, safety-net setting - Jetelina KK, Carr C, Murphy CC, Sadeghi N, S Lea J, Tiro JA.
PURPOSE: Characterize prevalence of intimate partner violence (IPV) among breast and cervical survivors receiving care in an urban safety-net healthcare system; Examine the relationship between IPV and clinical characteristics, receipt of cancer treatment,... (Source: SafetyLit)
Source: SafetyLit - July 20, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Pap/HPV Cotesting Better for Cervical Cancer Screening in Over 30s
TUESDAY, July 14, 2020 -- Liquid-based cytology (LBC) and human papillomavirus (HPV) cotesting enhances screening for cervical cancer (CxCa) and precancer among women aged 30 years and older, according to a study published online July 8 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancer
Basel, 13 July 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMagyn050 study showed that the addition of Tecentriq® (atezolizumab) to Avastin® (bevacizumab), paclitaxel and carboplatin did not meet its primary endpoint of progression-free survival (PFS) for the front-line treatment of women with newly diagnosed advanced stage ovarian cancer. Topline safety data indicate that safety for Tecentriq in combination with Avastin, paclitaxel and carboplatin was consistent with the known safety profile of the combination.“Ovarian cancer remains one of the most aggressive cancers a...
Source: Roche Media News - July 13, 2020 Category: Pharmaceuticals Source Type: news

Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancer
Basel, 13 July 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMagyn050 study showed that the addition of Tecentriq® (atezolizumab) to Avastin® (bevacizumab), paclitaxel and carboplatin did not meet its primary endpoint of progression-free survival (PFS) for the front-line treatment of women with newly diagnosed advanced stage ovarian cancer. Topline safety data indicate that safety for Tecentriq in combination with Avastin, paclitaxel and carboplatin was consistent with the known safety profile of the combination.“Ovarian cancer remains one of the most aggressive cancers a...
Source: Roche Investor Update - July 13, 2020 Category: Pharmaceuticals Source Type: news

Potential causal role of human papilloma viruses (HPVs) in prostate cancers
(BMC (BioMed Central)) Human papilloma viruses (HPVs) - a common group of viruses known to cause cervical cancers - may also have a causal role in prostate cancer, according to a literature review published in the open access journal Infectious Agents and Cancer, supporting the case for universal HPV vaccination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 13, 2020 Category: Cancer & Oncology Source Type: news

8.8 cr footfall recorded at health and wellness centres under Ayushman Bharat since Feb 1
In the last five months, 1.41 crore individuals were screened for hypertension, 1.13 crore for diabetes and 1.34 crore for oral, breast or cervical cancer, the ministry said. Despite the challenges posed by the COVID-19 pandemic, medicines were dispensed to about 5.62 lakh hypertension patients and 3.77 lakh diabetes patients at the HWCs in June alone, according to the statement. (Source: The Economic Times)
Source: The Economic Times - July 10, 2020 Category: Consumer Health News Source Type: news

Cotesting With Pap, HPV Tests More Likely to Detect Cervical Cancer, Precancer Cotesting With Pap, HPV Tests More Likely to Detect Cervical Cancer, Precancer
HPV or Papanicolaou test by liquid-based cytology alone are less likely to detect cervical cancer or precancer than combining both tests for the same specimen.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 9, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

NCI Funds Urban-Rural Cervical Cancer Screening Research
A new University of Rochester Medical Center, Department of Emergency Medicine study aims to reduce the screening disparity for cervical cancer, a highly preventable disease, with a study conducted at UR Medicine emergency departments in urban and rural locations. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - July 8, 2020 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Medicaid Expansion Contributing to Earlier Cancer Diagnosis
MONDAY, July 6, 2020 -- Among low-income adults, the odds of being diagnosed with metastatic breast, cervical, colorectal, or lung cancers decreased following Medicaid expansion in Ohio, according to a study published online July 6 in Cancer. Uriel... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 6, 2020 Category: Pharmaceuticals Source Type: news

Artificial Intelligence Provides Benefit for Cervical Cancer Screening
Automated dual - stained slide evaluation reduces number of colposcopies versus current standards (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 1, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Oncology, Pathology, Journal, Source Type: news

Artificial Intelligence Provides Benefit for Cervical Cancer Screening
WEDNESDAY, July 1, 2020 -- For women undergoing human papillomavirus (HPV)-based cervical cancer screening, automated evaluation of p16/Ki-67 dual-stained (DS) slides reduces the number of colposcopies compared with current standards, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 1, 2020 Category: Pharmaceuticals Source Type: news

Can at-home tests reduce rates of cervical cancer?
The National Cancer Institute plans to launch a study next year to assess whether at-home HPV tests can reduce rates of cervical cancer in the U.S. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - June 30, 2020 Category: Science Authors: Charlotte Huff Source Type: news

School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
FINDINGSA UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.In Rhode Island, the vaccination rate among adolescents was 91%, compared with an average of 78% in neighboring non-policy states. In the District of Columbia, the rate was 89%, compared with 72% for nearby non-policy states. Virginia, which is in the same region as the district, was the one state with a vaccination policy that showed no ...
Source: UCLA Newsroom: Health Sciences - June 29, 2020 Category: Universities & Medical Training Source Type: news

Nigeria: 40 Million Women in Nigeria at Risk of Cervical Cancer, Says Minister of Health
[Vanguard] Abuja -... Why FG can't implement prevention, control plan now, he explains (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 27, 2020 Category: African Health Source Type: news

Minimally Invasive Hysterectomy Tied to Worse Cervical Cancer Outcomes
Meta - analysis included 15 observational studies of minimally invasive hysterectomy versus open surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 26, 2020 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Journal, Source Type: news